Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by BearDownAZ


ESPR

ESPR Licensing Agreement with Daiichi Sankyo Europe (DSE)

Great news! Esperion Announces Agreement with Daiichi Sankyo Europe (DSE) to...

January 8, 2019

T.RVX

RE:RE:RE:RE:RE:RE:RE:RE:Slides up bio tech

It is extremely uncommon for companies to give such precise estimates for the...

January 8, 2019

T.RVX

RE:RE:RE:RE:RE:RE:Slides up bio tech

Yeah, unfortunately my president thinks out loud a lot too. I'm scared of...

January 8, 2019

T.RVX

RE:RE:RE:RE:Slides up bio tech

It was the exact same language as was in the December Corporate update. Why...

January 8, 2019

T.RVX

RE:RE:Slides up bio tech

Over, not at 200. Very likely on edge of 250. Top-line probably within 3...

January 7, 2019

V.BTI.H

RE:Isn’t Mon the 7th

There must have been a typo in the Bioasis press release. The 2nd Annual...

January 4, 2019

T.RVX

RE:RE:more BET publications and new indications?

"If we are to believe the latest December 2018, Corporate Presentation...

December 30, 2018

T.RVX

RE:When will we have the data...

Stevero, Here is a summary I posted on Agoracom the other day on...

December 28, 2018

T.RVX

RE:RE:RE:Results

It's been a while since Resverlogix commented on their other molecules...

December 21, 2018

T.RVX

RE:RE:RE:Results

G1945V and Rvxeasystreet, Nothing has changed in my opinion since my post on...

December 20, 2018

T.RVX

RE:RE:RE:RE:from IR/Sarah - thx to Kelsee from agor

Yes, Archman nailed it. Thanks for the voice of reason Archman. BearDownAZ

December 19, 2018

T.RVX

RE:RE:RE:RE:RE:CVD IN T2D

A small, but very important, correction pointed out by Jupe on Agoracom: I...

December 17, 2018

T.RVX

RE:RE:RE:RE:CVD IN T2D

JK, I watched and listened to the video last night. It is really good. A few...

December 17, 2018

T.RVX

RE:RE:CVD IN T2D

Jk, I didn't watch the video but saw the slides. It focuses on the SGLT2...

December 15, 2018

T.RVX

RE:How will the market interprets the MD&A + Financials

G1945V, I have a different take. After further thought, I'm not...

December 14, 2018

T.RVX

RE:RE:RE:RE:RE:RE:Number needed to treat for RVX-208, the NNT ?

Tundup provided some interesting insight into the apabetalone NNT in a...

November 29, 2018

T.RVX

RE:RE:RE:RE:Number needed to treat for RVX-208, the NNT ?

Here's an easy web tool for calculating NNT. Just plug in your expected...

November 29, 2018

T.RVX

RE:RE:RE:Number needed to treat for RVX-208, the NNT ?

"Any idea on an expected NTT?" NNT is the inverse of the absolute...

November 29, 2018

T.RVX

RE:Number needed to treat for RVX-208, the NNT ?

Thanks for sharing that link esopbykelso. However, I found it to be...

November 29, 2018

T.RVX

RE:RE:RE:RE:RE:Another peer reviewed article

I don't think Resverlogix ever abandoned plaque regressioon as one of the...

November 28, 2018